Bristol-Myers Squibb (BMY) Earnings Date & Reports
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders... Show more
BMY is expected to report earnings to fall 1.23% to $1.61 per share on February 05
Q4'25
Est.
$1.61
Q3'25
Beat
by $0.11
Q2'25
Beat
by $0.40
Q1'25
Beat
by $0.28
Q4'24
Beat
by $0.20
The last earnings report on October 30 showed earnings per share of $1.63, beating the estimate of $1.52. With 5.63M shares outstanding, the current market capitalization sits at 99.91B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BMY showed earnings on October 30, 2025. You can read more about the earnings report here.